Author (date) Funding | Objective | Eligibility Criteria | Evidence relevant to the overview | ||||
Population | Interventions | Comparators | Study designs | Outcomes | |||
Reviews of patient education interventions | |||||||
Adiewere (2018) [13] UK Funding: The Independent Diabetes Trust (UK) | To examine the effectiveness of patient education in preventing and reducing the incidence or recurrence of adult diabetic foot ulceration and amputation | Type I or type II diabetes mellitus or those with diabetic foot ulcers, aged ≥18 years; ulceration risk not specified | Intervention focused on patient education | Not specified | RCTs | Incidence of diabetic foot ulcers; amputation rates | 3 RCTs (Additional file 2: Supplementary references S2–S4) (n = 423) Ulcer risk: high Outcomes: ulceration; amputations Meta-analysis |
Ahmad Sharoni (2016) [29] Malaysia Funding: Not reported | To assess the effectiveness of health education programmes to improve foot self-care practices and foot problems among older people with diabetes | Older people with diabetes, average age ≥ 60 years; ulceration risk not specified | Educational programmes in relation to diabetes foot selfcare that included teaching, coaching, discussion, demonstration, and assessment, conducted by medical personnel | Not specified | Intervention studies (e.g. RCTs, non-randomised controlled study); studies with or without a control group | Primary outcome: diabetes foot self-care Secondary outcome: foot problems (neuropathy, lesion, ulcer, amputation, foot disability, callus, tinea pedis) | 1 RCT (Additional file 2: Supplementary reference S2) (n = 172) Ulcer risk: high Outcomes: ulceration; amputations Narrative summary |
Dorresteijn (2014) [15] Netherlands Funding: Cochrane review; no additional information | To assess the effects of patient education on the prevention of foot ulcers in patients with diabetes mellitus | Type 1 or type 2 diabetes mellitus, ≥18 years; ulceration risk not specified | Educational programmes or programmes that include education to reduce the incidence of foot ulceration; foot-care education as part of a larger educational programme or a more comprehensive diabetic foot programme | All types of control intervention | RCTs | Primary outcomes: foot ulceration or ulcer recurrence; amputation Secondary outcomes: Callus development; resolution of callus; fungal infection; number and duration of hospital admissions for diabetic foot problems; foot care knowledge scores; patients’ behaviour assessment scores | 2 RCTs (Additional file 2: Supplementary references S1, S2) (n = 225) Ulcer risk: high Outcomes: ulceration; amputations Narrative summary |
He (2013) [17] China Funding: Not reported | To assess the effectiveness of intensive versus routine education on diabetes mellitus for preventing diabetic foot ulcer | Type I or type II diabetes mellitus, ≥18 years, without current diabetic foot ulcer; ulceration risk not specified | Intensive diabetic education (any time, manner and duration of treatment) | Routine diabetes education | RCTs | Primary outcomes: incidence of diabetic foot ulcers; amputation rate Secondary outcomes: diabetes knowledge; quality of life | 2 RCTs (Additional file 2: Supplementary references S1, S2) (n = 225) Ulcer risk: high Outcomes: ulceration; amputations Meta-analysis |
Reviews of psychosocial interventions | |||||||
Author (date) Funding | Objective | Eligibility Criteria | Evidence relevant to the overview | ||||
Eligibility Criteria | Evidence relevant to the overview | Author (date) Funding | Objective | Eligibility Criteria | |||
McGloin (2021) [24] Ireland Funding: NIHR (UK) via Cochrane Wounds Group infrastructure funding | To evaluate the effects of psychological interventions on healing and recurrence of diabetic foot ulceration | People with a diabetic foot ulcer or a history of diabetic foot ulcer, ≥18 years; in any care setting | Psychological interventions: CBT; cognitive therapy; psychodynamic therapy; counselling; family systems or systemic therapy; other, as provided by a facilitator. | Standard care, another psychological intervention, education on healing and/or recurrence | RCTs, quasi-RCTs | Primary outcomes: complete wound healing, time to recurrence, number of recurrences Secondary outcomes: amputations (major or distal), health-related quality of life, self-efficacy, cost | 1 RCT (n = 41) (Additional file 2: Supplementary reference S25) Ulcer risk: High Outcomes: ulceration Analysis; narrative summary |
Norman (2020) [23] UK Funding: NIHR (UK) | Summarise the evidence for the effectiveness of psychosocial interventions to promote healing and/or reduce the occurrence of foot ulceration in people with diabetes | Type 1 or 2 diabetes with or without active foot ulceration; any ulceration risk level | Any individual or group psychological, behavioural or social intervention alone or in combination (eg CBT, motivational interviewing counselling, psychological therapy, social support, mindfulness) | Any, including alternative interventions, usual care, no treatment | RCTs | Primary outcomes: complete healing, ulceration Secondary outcomes: wound healing rate, amputation, foot care knowledge, adverse events, mortality, psychological outcomes, health related quality of life | 6 RCTs (n = 824) (Additional file 2: Supplementary references S1–S4, S12, S14) Ulcer risk: All levels Outcomes: ulceration Analysis: narrative summary |
Binning (2019) [27] UK Funding: Not reported | To determine whether motivational interviewing has been found to be an effective intervention to improve adherence behaviours for the prevention of diabetic foot ulceration | Diabetes of any type, aged ≥18 years, classified as “at risk” of developing diabetic foot ulceration as defined by the IWGDF, with current or recurrent ulceration or a co-existing risk factor | Motivational interviewing or a motivational approach as the sole intervention or as an intervention component; interventions solely aimed at improving knowledge and skills were excluded | All types of control intervention were accepted | Not pre-specified beyond studies without comparator groups were eligible if they were prospective with a before-and-after study design | A new episode of ulceration and/or at least one behavioural outcome measure | 1 RCT (Additional file 2: Supplementary reference S4) (n = 131) Ulcer risk: high Outcomes: ulceration Narrative summary |
Reviews of footwear and off-loading interventions | |||||||
Author (date) Funding | Objective | Eligibility Criteria | Evidence relevant to the overview | ||||
Population | Interventions | Comparators | Study designs | Outcomes | |||
Ahmed (2020) [38] Australia Funding: None | Evaluate the evidence for footwear and insole features that reduce pathological plantar pressures and diabetic neuropathy ulceration at the plantar forefoot in people with diabetic neuropathy | Diabetes, > 18 years; with or without neuropathy and foot deformity, history of plantar forefoot ulcers but no Charcot foot, history of heel ulcer or active foot ulcers | Footwear or insoles as a long-term offloading intervention; conventional materials and manufacturing techniques; closed-in footwear | Not specified | All study designs except systematic reviews and case reports | Outcomes: (re)-occurrence of forefoot ulcer or change in forefoot plantar pressure | 5 RCTs (n = 888) (Additional file 2: Supplementary references S7–S10, S19) Ulcer risk: High Outcomes: ulceration Analysis: Narrative synthesis |
Bus (2015) [32] Netherlands Funding: Not reported | To assess the effectiveness of footwear and offloading interventions to prevent or heal foot ulcers or reduce mechanical pressure in patients with diabetes | Type I or type II diabetes mellitus; ulceration risk not specified | Casting, footwear, surgical offloading, and other offloading techniques | Not specified | Systematic reviews, meta-analyses, RCTs, non-randomised controlled trials, case–control studies, cohort studies, controlled before-and-after studies, interrupted time series, prospective and retrospective uncontrolled studies, cross-sectional studies, case series | Ulcer prevention, ulcer healing, pressure reduction | 7 RCTs (Additional file 2: Supplementary references S5–S11) (n = 1554) Ulcer risk: high Outcomes: ulceration Analysis: Narrative summary |
Collings (2021) [40] UK Funding: NIHR (UK) | To identify the best footwear and insole design features for offloading the plantar surface of the foot to prevent foot ulceration in people with diabetic peripheral neuropathy | Type 1 or type 2 diabetes mellitus, > 18 years; peripheral neuropathy, nonulcerated feet, no major amputation of the foot or Charcot arthropathy | Therapeutic footwear and/or insole | Therapeutic footwear and/or insole design feature compared with another or no intervention | RCTs, non-randomised controlled trials, quasi-experimental, before and after studies, prospective and retrospective cohort studies, analytical cross-sectional studies | Primary outcome: foot ulcer incidence Other outcomes: kinetic, kinematic or clinical measures of plantar foot loading/offloading, side effects or adverse events | 7 RCTs (n = 1357) (Additional file 2: Supplementary references S5–S10, S18, S19) Ulcer risk: High Outcomes: ulcer Analysis: Narrative summary of RCT data |
Heuch (2016) [28] Australia Funding: Not reported | Review question: what is the effectiveness of methods of offloading in preventing primary DFUs in adults with diabetes? | Diabetes mellitus, ≥18 years, no history of foot ulceration | All offloading methods and strategies to prevent foot ulcers | Alternative offloading methods; all other comparators, including traditional treatment by a podiatrist | All quantitative study designs, including RCTs, quasi-experimental studies, cohort studies, case-control studies, and descriptive studies including case series and before-and-after studies | Primary outcome: prevention of primary diabetic foot ulcers Secondary outcome: indications of changes in pressure on the skin of the foot | 0 RCTs |
Healy (2013) [34] UK Funding: Not reported | To examine the effectiveness of footwear as an intervention for prevention of diabetic foot ulcers or the reduction of biomechanical risk factors for ulceration | Type I or type II diabetes mellitus, adults; ulceration risk not specified | Footwear as a preventive intervention | Alternative types of footwear | RCTs, quasi-experimental and observational studies with a control group or a repeated measure design | Ulceration/re-ulceration rates or biomechanical risk factors for ulceration (callus and plantar pressure measurement) | 2 RCTs (Additional file 2: Supplementary references S5, S6) (n = 469) Ulcer risk: high Outcomes: ulceration Narrative summary |
Paton (2011) [35] UK Funding: Not reported | To evaluate the effectiveness of insoles used for the prevention of ulcer in the neuropathic diabetic foot | Type I or type II diabetes mellitus, diagnosed with neuropathy, free from ulceration at study entry; ulceration risk not specified | Insoles | Not specified | RCTs, non-randomised control trials, follow-up/longitudinal studies | Primary outcome: time to ulceration Other outcomes: pressure measurement, patient-based response/patient perception, cost | 1 RCT (Additional file 2: Supplementary reference S5) (n = 69) Ulcer risk: high Outcomes: ulceration Narrative summary |
Maciejewski (2004) [36] USA Funding: Department of Veterans Affairs (USA) | To review the evidence for the effectiveness of therapeutic footwear in preventing re-ulceration in people with diabetes and foot risk factors | Individuals with diabetes and foot risk factors | Off the shelf therapeutic shoes with custom or generic inserts or custom shoes with custom inserts; used with other interventions or footwear reimbursement as the primary intervention | Not specified | RCTs, non-randomised controlled trials, analytic studies, descriptive studies | Prevention of re-ulceration | 2 RCTs (Additional file 2: Supplementary references S5, S6) (n = 469) Ulcer risk: high Outcomes: ulceration Narrative summary |
Spencer (2000) [20] UK Funding: Cochrane review; no external sources of support | To assess the effectiveness of pressure relieving interventions in the prevention and treatment of diabetic foot ulcers | Type 1 or Type 2 diabetes mellitus, with (treatment trials) or without (prevention trials) foot ulcers; ulceration risk not specified | Relief or redistribution of pressure in the neuropathic and/or neuroischaemic diabetic foot e.g. callus removal, orthoses including insoles, bespoke and customised shoes and casts | Not specified | RCTs | Time to complete healing or proportion of ulcer(s) completely healed in trial time, healing rates, recurrence rates, new ulceration, complications and morbidity, patient satisfaction, quality of life, presence of callus, cost effectiveness, cost benefit | 1 RCT (Additional file 2: Supplementary reference S5) (n = 69) Ulcer risk: high Outcomes: ulceration Narrative summary |
Reviews of complex Interventions | |||||||
Author (date) Funding | Objective | Eligibility Criteria | Evidence relevant to the overview | ||||
Population | Interventions | Comparators | Study designs | Outcomes | |||
Hoogeveen (2015) [16] Netherlands Funding: Cochrane review; NIHR (UK) via Cochrane Wounds Group infrastructure funding | To assess the effectiveness of complex interventions in the prevention of foot ulcers in people with diabetes mellitus | Type 1 or type 2 diabetes mellitus, ≥18 years; ulceration risk not specified | Complex intervention defined as an integrated care approach, combining ≥2 prevention strategies on at least two different levels of care (patient, healthcare provider and/or structure of health care) | Any comparison including single interventions, usual care, and alternative complex interventions | RCTs | Primary outcomes incidence of foot ulceration; partial or total amputation rates Secondary outcomes: callus development; resolution of callus; number and duration of hospital admissions for diabetes related foot problems; foot care knowledge scores; patients’ behaviour assessment scores; adverse events; costs | 3 RCTs (Additional file 2: Supplementary references S12–S14) n = 2455) Ulcer risk: All levels Outcomes: ulceration; amputations Narrative summary |
Blanchette (2020) [39] Canada Funding: None | What is the effect of contact with a podiatrist and their interventions in an MDT context on LEA and DFU in people with diabetes? | Type 1 or type 2 diabetes mellitus, ≥18 years; ulceration risk not specified | Educational prevention, foot care, offloading, infection control, wound care and surgical strategies delivered by a podiatrist in a multidisciplinary context or MDT programme | Interventions or treatments without an MDT context | RCTs, prospective or retrospective cohorts, comparative cohorts before and after | Primary outcomes: DFU or LEA occurrence Secondary outcomes: mortality/survival, DFU or LEA reoccurrence, other complications (infection), healthcare utilization, patient satisfaction | 0 RCTs |
Mayfield (2000) [37] USA Funding: Not reported | To evaluate the evidence supporting the Semmes-Weinstein monofilament and other threshold testing in preventing ulcers and amputation in people with diabetes | People with diabetes; ulceration risk not specified | Semmes-Weinstein monofilament or another threshold neuropathy assessment method that could be conducted in a primary care setting | A reference standard of foot ulceration or amputation (for diagnostic evaluations) | Not specified | Ulceration, amputation | 1 RCT (Additional file 2: Supplementary reference S13) (n = 1997) Ulcer risk: all levels Outcomes: ulceration; amputations Narrative summary |
Reviews of telehealth and temperature monitoring interventions | |||||||
Author (date) Funding | Objective | Eligibility Criteria | Author (date) Funding | ||||
Population | Interventions | Comparison | Study Designs | Outcomes | |||
da Silva (2020) [43] Brazil Funding: Not Reported | Assess the effect of mobile technologies as a tool in diabetic foot prevention and diagnosis in people with diabetes mellitus | Type 1 or type 2 diabetes mellitus; ulceration risk not specified | Mobile technology aimed at diabetic foot prevention, foot self-care, or diagnosis | NS | NS | NS | 0 RCTs |
Hazenberg (2020) [42] The Netherlands Funding: Not Reported | To assess the psychometric properties, feasibility, effectiveness, costs, and current limitations of telehealth and telemedicine approaches for prevention and management of diabetic foot disease | Diabetes mellitus with or at risk of developing a foot ulcer (risk defined according to the IWGDF as having peripheral neuropathy, with or without foot deformities, peripheral artery disease or lower-extremity amputation and/or a history of foot ulceration) | Any telehealth or telemedicine application, or medical tool that may potentially serve as a telehealth or telemedicine application | NS | RCTs, non-randomised trials, case-control studies, cohort studies, cross-sectional studies, case series, case reports, qualitative research | Validity, reliability, feasibility, effectiveness, costs in the outcome categories of monitoring, prevention, or treatment of diabetic foot disease | 4 RCTs (n = 524) (Additional file 2: Supplementary references S21–S23, S25) Ulcer risk: High Outcomes: ulceration Analysis: Narrative summary |
Ena (2021) [26] Spain Funding: None | To determine the effectiveness of the daily measurement of foot temperature in 6 points to prevent the occurrence of foot ulcers in patients with diabetes | Type 2 diabetes, at high risk of developing foot ulcers (history of neuropathy, deformity of the feet, or previous ulcer) | Twice daily monitoring of the temperature of the sole of the foot in 6 different locations along with the standard of care (use of insoles or orthopaedic footwear, education on diabetic foot prevention, routine foot care) | Standard of foot care (education, self-care practices, periodic clinical visits) | RCTs | Primary outcome: incidence of new foot ulcers (proportion of patients who developed a foot ulcer during follow-up) | 4 RCTs (n = 524) (Additional file 2: Supplementary references S21–S23, S25) Ulcer risk: High Outcomes: ulceration Analysis: meta analysis |
Reviews of physical activity and exercise interventions | |||||||
Author (date) Funding | Objective | Eligibility Criteria | Author (date) Funding | ||||
Population | Intervention | Comparison | Study design | Outcome | |||
Matos (2018) [44] Portugal Funding: NORTE2020, European Regional Development Fund | To analyse the effects of exercise and physical activity interventions on diabetic foot outcomes | A diagnosis of diabetes or diabetic peripheral neuropathy, polyneuropathy or DFU | Any form of supervised physical activity at home or a care centre | Daily life physical activity and/or usual foot care education | Controlled clinical trials | Diabetic foot outcomes | 1 RCT (n = 79) (Additional file 2: Supplementary reference S24) Ulcer risk: all levels Outcomes: ulceration Analysis: narrative summary |
Reviews of assorted preventive interventions | |||||||
Author (date) Funding | Objective | Eligibility Criteria | Evidence relevant to the overview | ||||
Population | Interventions | Comparators | Study designs | Outcomes | |||
Alahakoon (2020) [25] Australia Funding: James Cook University Strategic Research Investment Fund and other listed sources | Perform a systematic review and meta-analyses of RCTs of home foot temperature monitoring, education and offloading footwear for reducing the incidence of diabetes-related foot ulcers | Diabetes; IWGDF risk categories 2 or 3 without active diabetes-related foot ulcers | Home foot temperature monitoring, patient education, offloading footwear | Control group not receiving the intervention under study | RCTs | Primary outcome: DFU incidence (full thickness wound on the foot) Secondary outcomes: minor, major and total amputations | 17 RCTs (Additional file 2: Supplementary references S1–S10, S14, S19–S23, S25) (n = 2729) Ulcer risk: High Outcomes: ulceration, amputations Analysis: Meta analysis |
Arad (2011) [18] USA Funding: Not reported | To systematically assess RCTs regarding possible methods to prevent diabetic foot ulcers | People with diabetes, at risk of ulceration, with or without a history of previous foot ulcers | Primary and secondary prevention methods | Not specified | RCTs | Primary outcome: diabetic foot ulcers | 9 RCTs (Additional file 2: Supplementary references S2, S5, S6, S9, S12, S13, S21–S23) (n = 3816) Interventions: patient education (1 trial); footwear (3 trials); complex (2 trials); other (3 trials) Ulcer risk: high Outcomes: ulceration; amputations Narrative summary |
Crawford (2020) [14] UK Funding: Health Technology Assessment | To systematically review data from RCTs of interventions used to prevent foot ulcerations in diabetes. | people of any age with a diagnosis of type 1 or type 2 diabetes, with or without a history of ulceration, but free from foot ulceration at trial entry. | Simple interventions (e.g. education aimed at individuals with diabetes or physicians, or the provision of footwear) and complex interventions. | Standard Care or active treatments | RCTs | Incident or recurrent foot ulcers; also sought data on amputation; mortality; gangrene; infection; adverse events; harms; time to ulceration; quality of life; timing of screening; self-care; hospital admissions; psychological; and adherence to therapy | 22 RCTs (Additional file 2: Supplementary references S1–S15, S17, S21–S26) (n = 5410) Outcomes: ulceration, amputation Ulcer risk: all levels Analysis: meta analysis |
Dy (2017) [41] USA Funding: AHRQ | To assess benefits and harms of interventions for preventing diabetic peripheral neuropathy complications and treatment of symptoms | Type 1 or type 2 diabetes; ≥18 years; at risk for peripheral polyneuropathy | Pharmacologic (glucose lowering) focused on glucose control; Nonpharmacologic (foot care, surgical interventions, dietary strategies, lifestyle interventions, exercise and balance training) and surgical | Active interventions, usual care/placebo | Systematic reviews, RCTs, non-randomised studies with concurrent comparison groups | Incident or recurrent foot ulcer, falls, perceived fall risk, amputation, HRQoL, physical activity level, harms | 18 RCTs (n = 2778) (Additional file 2: Supplementary references S1, S3—S11, S14, S15, S17, S21–S25) Ulcer risk: all levels Outcomes: ulcer Analysis: meta analysis. |
O’Meara (2000) [19] UK Funding: Health Technology Assessment Board (UK) | To estimate the clinical and cost effectiveness of interventions for the prevention and treatment of diabetic foot ulcers | Diabetes mellitus, with a foot ulcer (treatment studies) or at risk of foot ulceration (prevention studies); ulceration risk not specified | Any intervention for the prevention and/or treatment of diabetic foot ulcers | Not specified | RCTs, non-RCTs with a contemporaneous control | Development or resolution of callus; incidence of ulceration; ulcer healing; ulcer recurrence rates; side effects; amputation rates | 4 RCTs (Additional file 2: Supplementary references S5, S12, S13, S26) (n = 2622) Interventions: footwear (1 trial); complex (2 trial); other (1 trial) Ulcer risk: all levels Outcomes: ulceration; amputations Narrative summary |
Mason (1999) [21] UK Funding: NHS Executive and British Diabetic Association | To evaluate the role of preventative strategies in reducing foot ulcers in patients with Type 2 diabetes mellitus, both in the general population and those identified to be at a raised risk | Type I or type II diabetes mellitus; ulceration risk not specified | Studies that addressed some aspect of screening, management, prevention or education relating to the foot care of people with diabetes | Not specified | RCTs, studies of lesser design | Not specified | 3 RCTs (Additional file 2: Supplementary references S5, S12, S13) (n = 2462) Ulcer risk: all levels Outcomes: ulceration; amputations Narrative summary |
Kaltenthaler (1998) [22] UK Funding: Not Reported | To review evidence on the effectiveness of interventions (including prevention) for diabetic foot ulcers | Diabetes; ulceration risk not specified | Prevention, multi-disciplinary education and support, treatments including topical applications, dressings, surgery, antibiosis, growth substances, hyperbaric oxygen, drug therapy, wound grafting, footwear and contact casts | Not specified | RCTs | Diabetic foot ulcers | 2 RCTs (Additional file 2: Supplementary references S5, S12) (n = 464) Ulcer risk: high Outcomes: ulceration Narrative summary |
van Netten (2020) [30] update of van Netten (2016) [31] Netherlands Funding: Not reported | To investigate the effectiveness of interventions to prevent first and recurrent foot ulcers in persons with diabetes who are at-risk for ulceration and do not have a current foot ulcer | Type I or type II diabetes mellitus, at risk of foot ulceration defined as presence of peripheral neuropathy, with or without a foot deformity or peripheral artery disease, or a history of foot ulcers or amputation of the foot or leg | Preventive interventions aimed at improvement in care, education of healthcare professionals, patient self- management, and medical interventions | Not specified | Systematic reviews, meta-analyses, RCTs, non-randomised controlled trials, case–control studies, controlled cohort studies, before-and-after studies, interrupted time series, prospective and retrospective non-controlled studies, cross-sectional studies, case series | Primary outcomes: first diabetic foot ulcer, recurrent diabetic foot ulcer | 20 RCTs (Additional file 2: Supplementary references S1–S11, S14–S17, S21–S25) (n = 2968) Outcomes: ulceration; amputations Narrative summary |